327
Views
0
CrossRef citations to date
0
Altmetric
Expression of Concern

Expression of Concern: Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial

This article refers to:
Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial

We, the Editors and Publisher of The Journal of Maternal-Fetal and Neonatal Medicine are issuing an expression of concern for the following article:

Nesreen A. A. Shehata, Hamada A. A. Ali, Ashraf S. Fahim, Maha A. Katta & Gaber K. Hussein (2020) Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial, The Journal of Maternal-Fetal & Neonatal Medicine, 33:10, 1631-1637, DOI: 10.1080/14767058.2018.1523892

After publication of this article, concerns about the statistical analysis and reporting in this article were brought to the Publisher and Editor’s attention. We reached out to the authors to request their raw data, which they have kindly provided. As this investigation may take some time to resolve, we advise readers to interpret the information presented in the article with due caution.

The authors have been notified about this Expression of Concern.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.